<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Recurrent TGCT Management &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/recurrent-tgct-management/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 06 Sep 2025 09:34:42 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Recurrent TGCT Management &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Understanding Tenosynovial Giant Cell Tumors in Kids</title>
		<link>https://bioengineer.org/understanding-tenosynovial-giant-cell-tumors-in-kids/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 09 Aug 2025 00:41:58 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[MRI Imaging for Childhood Tumors]]></category>
		<category><![CDATA[Pediatric TGCT Diagnosis Challenges]]></category>
		<category><![CDATA[Recurrent TGCT Management]]></category>
		<category><![CDATA[Targeted Therapy in Pediatric Oncology]]></category>
		<category><![CDATA[Tenosynovial Giant Cell Tumors in Children]]></category>
		<guid isPermaLink="false">https://bioengineer.org/understanding-tenosynovial-giant-cell-tumors-in-kids/</guid>

					<description><![CDATA[Notably, TGCT predominantly arises in the tendons of joints, manifesting as localized swellings or masses, yet its clinical presentations can be misleading. Physicians may encounter cases that resemble infectious processes or inflammatory reactions, thus complicating the diagnostic pathway. The challenge lies not solely in detection but also in distinguishing TGCT from other similar tumors, particularly [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">254808</post-id>	</item>
	</channel>
</rss>
